DJ Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slid 3.17% to $65.47 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
The stock's fall snapped a three-day winning streak.
Bristol Myers Squibb Co. closed 4.62% below its 52-week high of $68.64, which the company reached on August 19th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 2.21% to $267.37, Pfizer Inc. $(PFE)$ fell 1.59% to $27.79, and Abbott Laboratories $(ABT)$ fell 0.25% to $114.14.
Trading volume (9.4 M) remained 2.9 million below its 50-day average volume of 12.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.